Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.3 USD | -2.65% | -5.16% | +46.11% |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company shows low valuation levels, with an enterprise value at 0.57 times its sales.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The opinion of analysts covering the stock has improved over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Computer Hardware
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+46.11% | 1.63B | B- | ||
+20.21% | 5.41B | A- | ||
+13.71% | 4.43B | B- | ||
-3.80% | 1.58B | B+ | ||
+58.05% | 1.49B | B | ||
-3.85% | 1.46B | - | - | |
+15.29% | 1.2B | - | ||
+120.67% | 910M | - | ||
-1.11% | 658M | - | ||
-5.35% | 596M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- DBD Stock
- Ratings Diebold Nixdorf, Incorporated